Matches in Nanopublications for { ?s ?p "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826995.RARDzitddYz0oM7OGZAKfdjQ0MA20wYjn-CZty0QwWmQU130_provenance.
- assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP749376.RAFOv8rUawQrN-CRahLb5JwS0UKa7SM7lggLzpMUX2ruw130_assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749376.RAFOv8rUawQrN-CRahLb5JwS0UKa7SM7lggLzpMUX2ruw130_provenance.
- NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_provenance.
- NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468171.RATAzy4dFLVW5rRf5tCMYd2U3zhMA3wHretUuRRLynp3g130_provenance.
- NP882101.RAPOSyzjaAORiiWQ0iwweR_QAYJVTbRcqNBg54W8TeKjc130_assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882101.RAPOSyzjaAORiiWQ0iwweR_QAYJVTbRcqNBg54W8TeKjc130_provenance.
- NP330040.RA3KmI3e2cEWkFWJUo1eULIMk6Tu2IHSGMGyjq7ELzr28130_assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330040.RA3KmI3e2cEWkFWJUo1eULIMk6Tu2IHSGMGyjq7ELzr28130_provenance.
- NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.
- NP468170.RAKtUhMhFNLvmCEGfhFdgW8quRlc4Qwe1rl162eC1cHss130_assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468170.RAKtUhMhFNLvmCEGfhFdgW8quRlc4Qwe1rl162eC1cHss130_provenance.